Cargando…

Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations

Vaccination is a simple yet important process used to prevent many infections in the general population. For patients with suppressed immune systems, especially those who are undergoing chemotherapy or who have undergone stem cell transplant, repeat vaccination or boosters may be crucial in prolongi...

Descripción completa

Detalles Bibliográficos
Autor principal: Tsang, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093304/
https://www.ncbi.nlm.nih.gov/pubmed/25031932
_version_ 1782325698997780480
author Tsang, Vivian
author_facet Tsang, Vivian
author_sort Tsang, Vivian
collection PubMed
description Vaccination is a simple yet important process used to prevent many infections in the general population. For patients with suppressed immune systems, especially those who are undergoing chemotherapy or who have undergone stem cell transplant, repeat vaccination or boosters may be crucial in prolonging and/or extending immunity. The purpose of this review is to examine the need for each vaccine in two separate oncology populations: patients receiving concurrent chemotherapy and post–stem cell transplant patients. In addition, the importance of avoiding live vaccines and criteria for reconsideration at a future time will also be discussed.
format Online
Article
Text
id pubmed-4093304
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-40933042014-07-16 Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations Tsang, Vivian J Adv Pract Oncol Review Article Vaccination is a simple yet important process used to prevent many infections in the general population. For patients with suppressed immune systems, especially those who are undergoing chemotherapy or who have undergone stem cell transplant, repeat vaccination or boosters may be crucial in prolonging and/or extending immunity. The purpose of this review is to examine the need for each vaccine in two separate oncology populations: patients receiving concurrent chemotherapy and post–stem cell transplant patients. In addition, the importance of avoiding live vaccines and criteria for reconsideration at a future time will also be discussed. Harborside Press 2012 2012-03-01 /pmc/articles/PMC4093304/ /pubmed/25031932 Text en Copyright © 2012, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Tsang, Vivian
Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title_full Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title_fullStr Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title_full_unstemmed Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title_short Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
title_sort vaccination recommendations for the hematology and oncology and post–stem cell transplant populations
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093304/
https://www.ncbi.nlm.nih.gov/pubmed/25031932
work_keys_str_mv AT tsangvivian vaccinationrecommendationsforthehematologyandoncologyandpoststemcelltransplantpopulations